RxDoctor Payments Data

Heather Demaree

Medical · Jellico, TNNPI 1972930204

Payments from drug & device makers

$546in general payments, 2019–2025

Across 27 payments — averaging $20.21 each. Meals, travel, consulting and speaking fees, gifts and royalties reported by drug and device makers.

  • Otsuka America Pharmaceutical, Inc.$164
  • ITI, Inc. (d/b/a Intra-cellular Therapies, Inc.)$124
  • Bayer$72
  • Lundbeck LLC$64
  • GSK$34
  • Exact Sciences$22
  • plus $64 from 4 others

What the payments were for

  • Food & beverage$546100%

Most of this is food and beverage — typically meals provided during product presentations at a clinic or hospital. Nationally that is the single largest category of reported payments by count.

General payments by program year

22
23
24
25

Who reported the general payments

Companies are grouped under their corporate parent — a single manufacturer often files under several CMS reporting entities. Research and ownership payments are counted separately and are not in this table.

How this compares

$546 in reported general payments places this provider in the 50th percentile of 480 medical providers in Tennessee.

See all medical providers in Tennessee

Medicare billing

Part B allowed, 2024
$132
Medicare patients
18
Services billed
20

What this is not: this is the amount Original Medicare Part B allowed for services this provider billed in 2024. It is not their income. It excludes Medicare Advantage — now more than half of all Medicare enrollment — along with Medicaid and all commercial insurance, and it is gross practice revenue before staff, rent, supplies and malpractice premiums. CMS also suppresses any figure covering ten or fewer patients, so low-volume providers appear smaller than they are.

Most prescribed under Part D

DrugClaimsCost to plans & patients
OzempicSemaglutide100$108,387
JanuviaSitagliptin Phosphate71$56,020
EliquisApixaban67$45,251
FarxigaDapagliflozin Propanediol44$39,188
Trelegy ElliptaFluticasone/Umeclidin/Vilanter55$36,835
Tresiba Flextouch U-200Insulin Degludec31$29,274
RexultiBrexpiprazole20$29,096
Toujeo Max SolostarInsulin Glargine,hum.Rec.Anlog21$24,991
RybelsusSemaglutide18$23,016
TrulicityDulaglutide24$22,757
MounjaroTirzepatide20$21,218
JardianceEmpagliflozin18$17,935
MyrbetriqMirabegron23$17,243
XareltoRivaroxaban26$14,428
Breztri AerosphereBudesonide/Glycopyr/Formoterol11$10,866

Paid to pharmacies, not to this prescriber.

Companies that both paid and supply prescribed drugs

These companies both reported payments to this provider and make drugs the provider prescribed under Medicare Part D in 2024. For most specialties this overlap is expected — a cardiologist who is paid by a cardiology drugmaker also treats heart disease. It is shown so the reader can see it, not because it implies anything on its own.

CompanyPaid to this providerPart D cost of their drugs
AstraZenecaFarxiga, Breztri Aerosphere, Symbicort$13$53,87866 claims
GSKTrelegy Ellipta, Breo Ellipta, Shingrix$34$47,61091 claims
Lilly USA, LLCTrulicity, Mounjaro$16$43,97544 claims
Otsuka America Pharmaceutical, Inc.Rexulti$164$29,09620 claims
Johnson & JohnsonXarelto$15$14,42826 claims

Reading this fairly. The Part D column is what drug plans and patients paid pharmacies — this provider received none of it, and it reflects how many patients they treat and what those drugs cost. Against peers, this provider's reported payments sit in the 50th percentile of 480 medical providers in Tennessee.

Other medical in Jellico

See the full list for Tennessee

Where these figures come from

Is this you, or does something look wrong? →